The Application Notebook
As UPLC users convert or replace their existing HPLC systems with UPLC systems there is a transition period where a method must be run on both platforms. Thus, having the same particle substrate and bonded phases available in HPLC and UPLC particle sizes can significantly ease the burden of method development and transfer from one platform to another. In addition to the ethylene bridged hybrid (BEH) particle, three new high strength silica (HSS) stationary phases for HPLC applications are introduced. Scalability between both column diameter and particle size is demonstrated on both UPLC and HPLC instrumentation.
Zhe Yin, Kenneth J. Fountain, Doug McCabe and Diane M. Diehl, Waters Corporation, Milford, Massachusetts, USA.
As UPLC users convert or replace their existing HPLC systems with UPLC systems there is a transition period where a method must be run on both platforms. Thus, having the same particle substrate and bonded phases available in HPLC and UPLC particle sizes can significantly ease the burden of method development and transfer from one platform to another. In addition to the ethylene bridged hybrid (BEH) particle, three new high strength silica (HSS) stationary phases for HPLC applications are introduced. Scalability between both column diameter and particle size is demonstrated on both UPLC and HPLC instrumentation.
Systems: UPLC — ACQUITY UPLC and PDA HPLC — Alliance 2695 and 2998 PDA
Columns (Figure 1): ACQUITY UPLC HSS C18 SB
Columns (Figure 2): ACQUITY UPLC HSS C18, 3.5 µm,
Mobile phase A: 0.1% TFA in H2O
Mobile phase B: 0.1% TFA in MeCN
Figure 1 shows the scalability between UPLC and HPLC columns for the separation of paroxetine-related compounds on HSS C18 SB. Gradient, flow-rate and injection volume were properly scaled between different particle sizes and column dimensions. The system volume was properly compensated for when transferring method between UPLC and HPLC instrumentations. Chromatographic resolution and selectivity were maintained across all separation platforms.
Figure 1
Figure 2 demonstrates the scalability between columns with different internal diameters for the separation of a forced degradation sample of glimepiride.
Figure 2
A successful method transfer requires careful consideration of key parameters including system volume, column dimension and particle size, injection volume and gradient profile. Methods can be easily transferred between different systems (UPLC → HPLC → prep), particle sizes and column diameters on the new HSS columns.
For the complete application note, visit www.waters.com/32122
© 2009 Waters Corporation. Waters, The Science of What's Possible, UPLC and ACQUITY UPLC are trademarks of Waters Corporation.
Waters Corporation
34 Maple Street, Milford, Massachusetts 01757, USA
tel. +1 508 478 2000 fax +1 508 478 1990
Website: www.waters.com
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
GPCRs – The Biological Traffic Modulator: Chromatographic Analysis of Peptides in the GI Tract
January 20th 2025The G protein-coupled receptors (GPCR) are found throughout the entire body and have shown significance in the development of new therapeutic treatments. Isolation of seven classic GRPC peptides initiating in the GI tract highlights the benefits of using the polymer-based PRP-3, a reversed-phase resin. The covalent bonds found in the PRP-3 exhibit advantageous interactions between the biological π bonds found in the peptides and the available aromatic benzyl rings of the resin.